Companies similar to DYNAMIC CELL THERAPIES
Sign up to Download

1-30 of 5,056,482 results

  • www.dynamiccelltherapies.com
  • 1
  • 1
Dynamic Cell Therapies is developing controllable CAR T cells to address difficult-to-treat cancers. Our platform technology of dynamic control of engineered T cells will improve the safety, efficacy, and durability of CAR T cell therapies. This..
Relevance: 52.988438
  • www.genecellbt.com
  • 1
  • 5
  • 1
GeneCELL BT is dedicated to the cure of cancer and autoimmune diseases through the use of immune cell therapies, CAR-T, CAR-NK and CAR-Macrophage... We have focused initially on CAR-T treatment therapies because T cells are the most powerful cells..
Relevance: 45.059677
  • kyvernatx.com
  • 7
  • 1
  • 19
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases... Kyverna is pioneering CAR T-cell therapies for autoimmune disease patients by harnessing..
Relevance: 43.93462
  • cytoart.com
  • 2
  • 1
Cytoart is a biotechnology company aimed at improving the development, quality control and clinical monitoring of CAR T-cell therapies. By offering our comprehensive anti-idiotypic platform, we are a leading provider of companion diagnostics for CAR..
Relevance: 43.14466
  • chinacartcell.com
  • 3
  • 1
Albert on The cost of CAR-T preparation in China is much cheaper than in the USA... CAR-T cell therapy or Chimeric antigen receptorTcell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing..
Relevance: 43.136486
  • www.haemalogix.com
  • 1
  • 13
HaemaLogiX is researching immune based treatments (Monoclonal Antibodies, CAR T cell therapies and Bispecific antibodies) that target unique antigens on malignant cells to treat patients suffering from blood cancers (Multiple Myeloma) and other life-..
Relevance: 43.122395
  • www.cyteph.bio
  • 2
  • 1
  • 6
Cyteph is an Australian biotechnology company developing off-the-shelf T cell and CAR T cell therapies, harnessing the power of the immune system to target and destroy solid tumours... Cyteph is a spin-out company from QIMR Berghofer Medical..
Relevance: 42.2714
  • celularity.com
  • 24
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent..
Relevance: 41.86741
  • wugen.com
  • 2
  • 23
Our cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute..
Relevance: 41.858814
  • www.famicordtx.com
  • 1
  • 3
  • 1
FamiCordTx is a company established to implement cell engineering therapies. Our main goal is to implement therapy based on CAR-T (chimeric antigen receptor) technology, i.e. genetically modified T-cells used for blood neoplasm treatment.wi...
Relevance: 40.680653
  • genomefrontier.com
  • 1
  • 1
  • 5
Using the Quantum Engine™, GenomeFrontier is developing multiple cell modified gene therapy products, including chimeric antigen receptor T (CAR-T) and T cell receptor T (TCR-T) therapies. These are live, cell-based "drugs" composed of immune cells..
Relevance: 40.167305
  • celyad.com
  • 2
  • 2
  • 14
Celyad Oncology is a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary technologies for chimeric antigen receptor (CAR) T-cells. Its primary objective is to unlock the potential of its..
Relevance: 38.92786
  • www.biontech.com
  • 3
  • 3
  • 13
We aim to bring novel oncology and infectious disease therapies to the market. BioNTech is also exploring how to apply its technology to advancements in treating allergies, inflammatory diseases, and regenerative medicine... BioNTech is a fully..
Relevance: 37.17584
  • www.t-knife.com
  • 3
  • 3
  • 12
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer... We are focused on T cell receptor engineered T cell therapies, TCR-Ts, a promising modality that holds the potential to generate..
Relevance: 36.88703
  • www.for2799.de
  • 9
  • 2
  • 2
Current research on γδ T cells and their γδ TCR focusses on the identification of potential ligands for the γδ TCR, the role of γδ T cells in the control of infectious diseases, and the potential of γδ T cells for novel therapies against tumors...
Relevance: 36.834988
  • minktherapeutics.com
  • 1
  • 1
  • 6
MiNK Therapeutics is a clinical-stage precision oncology company developing allogeneic, invariant natural killer T cell therapies for cancer and other immune-mediated diseases. The lead product is an off-the-shelf, cell therapy based on a targeted..
Relevance: 36.637093
  • jabious.com
  • 1
  • 2
JA Bio is a startup bio-tech company located at Cambridge in Massachusetts. We are focusing on anti-cancer cell immune therapeutics discovery and development. Our research includes,... Based on NBRL (nbrm.org) developed immune cell therapy, JA Bio..
Relevance: 36.47933
  • www.axistherapeutics.com
  • 1
  • 14
Axis Therapeutics is a leading cancer immunotherapy company focused on the development of T cell therapies... Axis Therapeutics is developing cell-based therapies that take advantage of the unique attributes of TCR mediated target recognition...
Relevance: 36.412872
  • www.hershbhargava.com
  • 1
We built a synthetic circuit that wires tumor antigen detection to cytokine production in T cells. This circuit produces the inflammatory cytokine IL-2 at super-physiological levels, and enables engineered T cells to overcome imunosuppressive "cold"..
Relevance: 36.31367
  • www.glycostem.com
  • 2
  • 1
  • 15
Glycostem is developing a pipeline of cellular immunotherapy therapies, which has the potential to redefine standards of care across various type of cancer. Besides of oNKord® as our lead investigational product, we are developing viveNK TM, Chimeric..
Relevance: 36.294037
  • www.cero.bio
  • 1
  • 3
  • 5
We are advancing a CER T-cell platform that potentially offers novel approaches for the treatment of both hematologic malignancies and solid tumors... CERo's novel approach to fighting cancer aims to harness the power of the body's innate and..
Relevance: 36.14517
  • in8bio.com
  • 1
  • 1
  • 21
IN8bio was founded with the mission of developing next-generation cellular therapies for treating cancer. Dr. Lawrence Lamb, one the Company's co-founders, is a leader in the field of gamma-delta T cells. During his postdoctoral fellowship in..
Relevance: 35.697117
  • medisixtx.com
  • 9
Visionary scientist and creator of the first anti-CD19 CAR, Professor Dario Campana established MediSix Therapeutics in 2016 to help patients with complex and rare T-cell malignancies... We believe that T-cell therapies will radically change the..
Relevance: 35.17988
  • www.aurora-biopharma.com
  • 1
  • 2
  • 13
Aurora Biopharma is founded on a single mission to revolutionize the treatment of cancer, by using the human body's immune system. Aurora is developing state-of-the-art cancer immunotherapy, a form of adoptive cell transfer called Chimeric Antigen..
Relevance: 35.178818
  • catamaranbio.com
  • 2
  • 1
  • 20
We are driven to realize the full potential of cell therapy by powering a key type of immune cell, Natural Killer (NK) cells, with new properties to create transformative cancer treatments for more patients. Using synthetic biology and non-viral cell..
Relevance: 34.580643
  • triumvira.com
  • 1
  • 6
  • 12
Triumvira is developing unique, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat a broad range of patients with cancer... Our partners have independently validated our technology in..
Relevance: 34.442127
  • www.gracellbio.com
  • 2
  • 1
Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapy. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is..
Relevance: 34.269356
  • pancancer-t.com
  • 1
  • 13
Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer... TCR-T therapy is based on genetically modified T cells directed against specific targets on tumor cells. Pan Cancer T´s differentiated Next..
Relevance: 34.260075
  • irvine-lab.mit.edu
  • 21
  • 3
  • 18
Engineering approaches grounded in immunology hold the key to the discovery and development of novel treatments for cancer, infectious disease, and autoimmunity. To this end, the overarching goal of our laboratory is to engineer immunity through a..
Relevance: 34.17194
  • tcbiopharm.com
  • 4
  • 1
  • 7
TC BioPharm (TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious..
Relevance: 33.722076